The Journal of Urology
Volume 182, Issue 2 , Pages 616-625 , August 2009

Association of Lower Urinary Tract Symptoms and the Metabolic Syndrome: Results From the Boston Area Community Health Survey

  • Varant Kupelian

      Affiliations

    • New England Research Institutes, Watertown, Massachusetts
    • Corresponding Author InformationCorrespondence: New England Research Institutes, 9 Galen St., Watertown, Massachusetts 02472 (telephone: 617- 923-7747 ext 293; FAX: 617-924-0968)
    • ,
  • Kevin T. McVary

      Affiliations

    • Department of Urology, Northwestern University, Chicago, Illinois
    • Financial interest and/or other relationship with GlaxoSmithKline, Pfizer, Lilly/ICOS, Sanofi-Aventis, Allergan, and the National Institute of Diabetes and Digestive and Kidney Diseases.
    • ,
  • Steven A. Kaplan

      Affiliations

    • Cornell University, Weill Medical College, New York, New York
    • ,
  • Susan A. Hall

      Affiliations

    • New England Research Institutes, Watertown, Massachusetts
    • ,
  • Carol L. Link

      Affiliations

    • New England Research Institutes, Watertown, Massachusetts
    • ,
  • Lalitha Padmanabhan Aiyer

      Affiliations

    • Pfizer Inc, New York, New York
    • Financial interest and/or other relationship with Pfizer, Inc.
    • ,
  • Patrick Mollon

      Affiliations

    • Pfizer Ltd, Global Medical and Outcomes Research, Sandwich, United Kingdom
    • ,
  • Nihad Tamimi

      Affiliations

    • Pfizer Inc, New York, New York
    • Financial interest and/or other relationship with Pfizer, Inc.
    • ,
  • Raymond C. Rosen

      Affiliations

    • New England Research Institutes, Watertown, Massachusetts
    • Financial interest and/or other relationship with Pfizer Inc., Eli Lilly, Bayer Schering, Sanofi Aventis and Boehringer Ingelheim.
    • ,
  • John B. McKinlay

      Affiliations

    • New England Research Institutes, Watertown, Massachusetts
    • Requests for reprints: New England Research Institutes, 9 Galen St., Watertown, Massachusetts 02472 (telephone: 617-923-7747 ext. 512; FAX: 617-926-8246; e-mail: bach@neriscience.com).

Received 2 December 2008

References 

  1. Fitzgerald MP, Link CL, Litman HJ, et al. Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses. Eur Urol. 2007;52:407
  2. Joseph MA, Harlow SD, Wei JT, et al. Risk factors for lower urinary tract symptoms in a population-based sample of African-American men. Am J Epidemiol. 2003;157:906
  3. Michel MC, Mehlburger L, Schumacher H, et al. Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Urol. 2000;163:1725
  4. Rohrmann S, Smit E, Giovannucci E, et al. Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III). Int J Obes (Lond). 2005;29:310
  5. Giovannucci E, Rimm EB, Chute CG, et al. Obesity and benign prostatic hyperplasia. Am J Epidemiol. 1994;140:989
  6. Hammarsten J, Hogstedt B, Holthuis N, et al. Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 1998;1:157
  7. Parsons JK, Carter HB, Partin AW, et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab. 2006;91:2562
  8. Rohrmann S, Smit E, Giovannucci E, et al. Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2004;159:390
  9. Burke JP, Rhodes T, Jacobson DJ, et al. Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia. Am J Epidemiol. 2006;164:41
  10. Meigs JB, Mohr B, Barry MJ, et al. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol. 2001;54:935
  11. Rosen RC, Giuliano F, Carson CC. Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Eur Urol. 2005;47:824
  12. Platz EA, Kawachi I, Rimm EB, et al. Physical activity and benign prostatic hyperplasia. Arch Intern Med. 1998;158:2349
  13. Platz EA, Rimm EB, Kawachi I, et al. Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia. Am J Epidemiol. 1999;149:106
  14. Rohrmann S, Crespo CJ, Weber JR, et al. Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men: findings from the third National Health And Nutrition Examination Survey. BJU Int. 2005;96:77
  15. Hammarsten J, Hogstedt B. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood Press. 1999;8:29
  16. Hammarsten J, Hogstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol. 2001;39:151
  17. McKinlay JB, Link CL. Measuring the urologic iceberg: design and implementation of the Boston Area Community Health (BACH) Survey. Eur Urol. 2007;52:389
  18. Barry MJ, Fowler FJ, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia (The Measurement Committee of the American Urological Association). J Urol. 1992;148:1549
  19. Badia X, Garcia-Losa M, Dal-Re R, et al. Validation of a harmonized Spanish version of the IPSS: evidence of equivalence with the original American scale (International Prostate Symptom Score). Urology. 1998;52:614
  20. Epstein RS, Deverka PA, Chute CG, et al. Validation of a new quality of life questionnaire for benign prostatic hyperplasia. J Clin Epidemiol. 1992;45:1431
  21. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486
  22. Kupelian V, Shabsigh R, Araujo AB, et al. Erectile dysfunction as a predictor of the metabolic syndrome in aging men: results from the Massachusetts Male Aging Study. J Urol. 2006;176:222
  23. Washburn RA, Smith KW, Jette AM, et al. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol. 1993;46:153
  24. Green LW. Manual for scoring socioeconomic status for research on health behavior. Public Health Rep. 1970;85:815
  25. Schafer JL. Analysis of Incomplete Multivariate Data. London: Chapman and Hall; 1997;
  26. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care. 2004;27:2444
  27. Boyle P, Robertson C, Mazzetta C, et al. The prevalence of lower urinary tract symptoms in men and women in four centres (The UrEpik study). BJU Int. 2003;92:409
  28. Link CL, McKinlay JB. Does America's expanding waistline increase the likelihood of urologic symptoms? (Results from the Boston Area Community Health (BACH) study). J Urol. 2008;179(suppl.):141;abstract 398
  29. Cellek S, Rodrigo J, Lobos E, et al. Selective nitrergic neurodegeneration in diabetes mellitus - a nitric oxide-dependent phenomenon. Br J Pharmacol. 1999;128:1804
  30. Kasturi S, Russell S, McVary KT. Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia. Curr Urol Rep. 2006;7:288
  31. McVary KT, Monnig W, Camps JL, et al. Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized double-blind trial. J Urol. 2007;177:1071
  32. McVary KT, Roehrborn CG, Kaminetsky JC, et al. Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2007;177:1401
  33. Ponholzer A, Madersbacher S. Lower urinary tract symptoms and erectile dysfunction; links for diagnosis, management and treatment. Int J Impot Res. 2007;19:544
  34. Shenfeld OZ, Meir KS, Yutkin V, et al. Do atherosclerosis and chronic bladder ischemia really play a role in detrusor dysfunction of old age?. Urology. 2005;65:181
  35. Brown JS, Wessells H, Chancellor MB, et al. Urologic complications of diabetes. Diabetes Care. 2005;28:177
  36. Starer P, Libow L. Cystometric evaluation of bladder dysfunction in elderly diabetic patients. Arch Intern Med. 1990;150:810
  37. Ueda T, Yoshimura N, Yoshida O. Diabetic cystopathy: relationship to autonomic neuropathy detected by sympathetic skin response. J Urol. 1997;157:580

 Study received institutional review board approval.

 Supported by Pfizer, Inc.

 The BACH survey is supported by DK 56842 from the National Institute of Diabetes and Digestive and Kidney Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes and Digestive and Kidney Diseases or the National Institutes of Health.

PII: S0022-5347(09)00934-3

doi: 10.1016/j.juro.2009.04.025

The Journal of Urology
Volume 182, Issue 2 , Pages 616-625 , August 2009

Article Tools

* Image Usage & Resolution